Last reviewed · How we verify

Direct Oral challenge — Competitive Intelligence Brief

Direct Oral challenge (Direct Oral challenge) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Area: Allergy/Immunology.

marketed Allergy/Immunology Small molecule Live · refreshed every 30 min

Target snapshot

Direct Oral challenge (Direct Oral challenge) — Johns Hopkins University. Direct oral challenge is a diagnostic procedure that administers an allergen or suspected trigger orally under controlled medical supervision to assess allergic or adverse reactions.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Direct Oral challenge TARGET Direct Oral challenge Johns Hopkins University marketed

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape

No sponsor landscape data.

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Direct Oral challenge — Competitive Intelligence Brief. https://druglandscape.com/ci/direct-oral-challenge. Accessed 2026-06-09.

Build your own brief

Pick any drug + add comparators:

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing